TKPHF:OTCMKTS
Takeda Pharmaceutical Co Ltd
US$33,85
0,00%
(0,00) 1D
6 ຕ.ລ., 11 ໂມງ 51 ນາທີ 40 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TKPHF...
Mkt. cap
58,91 ຕື້
Avg. vol.
2,50 ພັນ
Volume
0,00
52-wk high
US$39,20
52-wk low
US$26,33
Beta
-2,60
Shares outstanding
1,60 ຕື້
No. of employees
47 ພັນ
Mkt. cap
58,91 ຕື້
Avg. vol.
2,50 ພັນ
Volume
0,00
52-wk high
US$39,20
52-wk low
US$26,33
Beta
-2,60
Shares outstanding
1,60 ຕື້
No. of employees
47 ພັນ
News stories
From web sources and news partners
AD HOC NEWS
·
2 ຊົ່ວໂມງກ່ອນ
Takeda presents oncology data and Takeda stock costs EUR 16.55
AD HOC NEWS
·
6 ຊົ່ວໂມງກ່ອນ
Takeda Pharmaceutical stock pre-market at EUR 16.55: unchanged
TipRanks
·
19 ຊົ່ວໂມງກ່ອນ
Takeda’s CDPATH™ Study Signals Growing Focus on Data‑Driven Crohn’s Care
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47 ພັນ
Founded12 ມິ.ຖ. 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com